LifeStance Health Group Sees Unusually High Options Volume (NASDAQ:LFST)

LifeStance Health Group, Inc. (NASDAQ:LFST) was the target of some unusual options trading activity on Tuesday. Traders acquired 4,000 put options on the company. This is an increase of approximately 292% compared to the average daily volume of 1,020 put options.

Wall Street Analyst Weigh In

LFST has been the topic of a number of research analyst reports. William Blair reiterated an “outperform” rating on shares of LifeStance Health Group in a report on Friday, February 28th. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective on the stock in a report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $8.63.

Insider Activity

In related news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $6.90, for a total transaction of $130,030.50. Following the transaction, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. This represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 6.60% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of LFST. Jennison Associates LLC boosted its stake in shares of LifeStance Health Group by 278.4% during the 4th quarter. Jennison Associates LLC now owns 8,086,380 shares of the company’s stock worth $59,597,000 after acquiring an additional 5,949,438 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of LifeStance Health Group by 87.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company’s stock valued at $25,977,000 after buying an additional 1,643,390 shares during the last quarter. Vanguard Group Inc. grew its position in LifeStance Health Group by 7.9% in the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company’s stock worth $78,781,000 after acquiring an additional 784,818 shares in the last quarter. Geode Capital Management LLC increased its position in LifeStance Health Group by 26.8% during the third quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company’s stock worth $24,170,000 after buying an additional 729,794 shares during the last quarter. Finally, Wellington Management Group LLP boosted its position in LifeStance Health Group by 15.2% during the third quarter. Wellington Management Group LLP now owns 4,830,441 shares of the company’s stock worth $33,813,000 after purchasing an additional 638,385 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $6.63 on Thursday. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19. The firm has a 50-day simple moving average of $7.52 and a 200 day simple moving average of $7.34. LifeStance Health Group has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The company has a market cap of $2.55 billion, a PE ratio of -25.50 and a beta of 1.27.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.